Biogen · Health Care
BIIB
$205.99
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the treatment of neurological diseases.百健公司是一家美国跨国生物技术公司，总部位于美国马萨诸塞州剑桥，专注于神经系统疾病治疗。
Mixed profile混合特征
Large cap大盘
$30B
Engine stance引擎立场2026-07-20
Constructive — building a base建设性 — 正在筑底
The daily turn is already in — a low formed ~3 day(s) ago @ 191.95 and price is back above the 10-day average. What's mi日线转向已经完成——低点于约 3 天前形成 @ 191.95，且价格已重新站上 10 日均线。尚缺的是周线周期的确认，因此这是当下可用的部分信心入场，而非待触发信号：可在此建半仓，或等待周线转向。
Key Statistics关键统计
Price价格
$205.99
4.9% below 52-week high低于52周高点 4.9%
Market Cap市值
$30B
Normal volume正常成交量
P/E Ratio市盈率
23.4x
28.9x sector median
Beta贝塔
0.23
Moves about 0.2x the market波动幅度约为市场的 0.2 倍
RSI (14)RSI（14）
53
Neutral zone中性区域
Next Earnings下次财报
2026-07-30 (11d)
Volatility Rank波动率分位
100th pctile
hist. vol. percentile历史波动率分位数
Short Interest空头兴趣
3.9% of float
Performance价格表现
| Period周期 | BIIB | S&P 500 | vs Index对比指数 |
|---|---|---|---|
| 1 Week近1周 | +3.4% | -1.5% | Beat the index by 4.9 points跑赢指数 4.9 个百分点 |
| 1 Month近1月 | +3.7% | +0.6% | Beat the index by 3.1 points跑赢指数 3.1 个百分点 |
| 3 Months近3月 | +16.1% | +4.7% | Beat the index by 11.4 points跑赢指数 11.4 个百分点 |
| 6 Months近6月 | +25.3% | +7.8% | Beat the index by 17.5 points跑赢指数 17.5 个百分点 |
| Year to date年初至今 | +15.8% | +9.1% | Beat the index by 6.7 points跑赢指数 6.7 个百分点 |
| 1 Year近1年 | +60.1% | +19.4% | Beat the index by 40.7 points跑赢指数 40.7 个百分点 |
Technicals技术面
RSI (14)RSI（14）
53
Neutral zone中性区域
vs 50-day相对50日均线
+3.6% vs 50-day avg
vs 200-day相对200日均线
+14.0% vs 200-day avg
Volatility rank波动率分位
100th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$201.80
Don't chase above不追高于
$209.40
Stop止损
$191.90
Cycle turn — awaiting confluence cross周期拐点 — 等待共振交叉确认
Earnings财务业绩
11
days until next report天后公布财报
2026-07-30
Estimates being raised — 2 analysts预期上调 — 2 位分析师
Post-earnings drift: -4.5% (20d)财报后漂移：-4.5%（20日）
Earnings call transcripts — coming soon财报电话会议记录 — 即将上线
Valuation估值
| Multiple指标 | BIIB | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（历史） | 23.39x | 28.92 | 65% |
| P/S市销率 | 3.06x | 3.02 | 49% |
| Earnings yield盈利收益率 | 4.28% | 2.72 | 74% |
| FCF yield自由现金流收益率 | 6.78% | 3.94 | 81% |
| P/FCF市值/自由现金流 | 14.75x | 22.42 | 78% |
Analyst price targets — coming soon分析师目标价 — 即将上线
Financials财务数据
Revenue营业收入
5yr CAGR5年复合增速: -6.0%
Earnings Per Share每股收益
5yr CAGR5年复合增速: -18.7%
Free Cash Flow自由现金流
Margins利润率
4.4%Return on Assets资产回报率
Leverage杠杆
| Current ratio流动比率 | 2.68 |
Capital Allocation资本配置
| Stock-based comp股权薪酬 | $290.8M |
| Share count change (1y)股数变化（1年） | +0.7% |
Piotroski皮奥特罗斯基 5/9
Altman Z阿尔特曼Z: safe (3.2)
Watch关注
Snapshot Gauges综合指标
Valuation vs Sector估值相对行业
Looks cheap vs sector相对行业偏便宜
Cheaper than 65% of its sector on blended multiples综合估值倍数低于行业内 65% 的公司
Beta市场敏感度
0.23×
0.21×3×
Moves about 0.2× the market波动幅度约为市场的 0.2 倍
Financial Health财务健康
5/9
Altman阿尔特曼: safe
Adequate financial health财务健康状况一般
Dividend分红
—
Does not pay a dividend不派发股息
Why Is It Moving为何波动
Sector / Theme行业/主题
Big Pharma theme — #3 of 46 themes「大型药企」主题 — 46 个主题中第 3 位
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Short interest changed +10.3%空头仓位变动 +10.3%
Technical技术面
BIIB StochRSI turned up from oversoldBIIB StochRSI自超卖区上行
Options Positioning期权持仓
Market makers are net long gamma — price pinned near current level做市商净持有正伽玛，价格倾向于在当前水平附近震荡
Expected daily move预期日波动
±2.63%
Expected weekly move预期周波动
±5.88%
Call wall看涨密集区
$210
Put wall看跌密集区
$190
25d risk reversal25d风险逆转
2.1%
Skew: 偏斜：greed
Ownership & Smart Money持仓与聪明钱
Insider activity内部人员活动: -$0.7M net (0 buyers, 1 sellers)-$0.7M 净值（0 买家，1 卖家）
| Fund基金 | Grade评级 | Activity动作 | % of portfolio组合占比 | As of截至 |
|---|---|---|---|---|
| Perceptive Advisors | A | exitexit | 0.0% | 2026-03-31 |
Signal History信号历史
TURN SIGNALED
BOTTOMING
Jul 16, 2026
BIIB StochRSI turned up from oversoldBIIB StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $208.92.StochRSI重回20上方 — 下行动量趋缓的最早预警。$208.92。
Jul 15, 2026
NEARING A LOW → BOTTOMING接近低点 → 筑底中
BUY SETUP买入预备
Jul 14, 2026
BIIB broke down vs the marketBIIB 相对市场走弱
Relative strength vs SPY crossed below the 10th percentile of the last 90 days — weakness often leads price. $191.95.相对标普500的强弱下穿近90日的第10百分位 — 走弱常先于价格。$191.95。
Jul 13, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jul 8, 2026
BIIB daily MACD crossed downBIIB 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $200.36.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$200.36。
Jul 7, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jul 2, 2026
BIIB took relative-strength leadershipBIIB 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $216.12.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$216.12。
Showing last 15 of显示最近15条，共 110 signals条信号
Factor Profile因子特征
Composite factor score综合因子得分: -0.05
Value价值
-0.2
Quality质量
-0.4
Investment资本投入
+0.2
Low volatility低波动
+0.2
Low market beta低市场敏感度
+0.8
Earnings quality盈利质量
-0.3
Short interest空头兴趣
+0.1
Company Profile公司档案
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the treatment of neurological diseases.百健公司是一家美国跨国生物技术公司，总部位于美国马萨诸塞州剑桥，专注于神经系统疾病治疗。
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析，覆盖所有标普500成分股。